BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Analysis

DR Horton stock slips after Q1 earnings miss; revenues rise 6%

Shares of DR Horton Inc. (DHI) dropped modestly Friday after the homebuilding company reported weaker than expected earnings for the first quarter of 2019. Revenues, meanwhile, increased and topped the street view, benefitting from favorable pricing and strong demand for new homes. First-quarter revenues grew 5.6% to $3.52 billion and came in above analysts’ estimate. […]

January 25, 2019 2 min read

Shares of DR Horton Inc. (DHI) dropped modestly Friday after the homebuilding company reported weaker than expected earnings for the first quarter of 2019. Revenues, meanwhile, increased and topped the street view, benefitting from favorable pricing and strong demand for new homes.

DR Horton Q1 earnings miss estimates
DR Horton Q1 2019 earnings infographic

First-quarter revenues grew 5.6% to $3.52 billion and came in above analysts’ estimate. Net income attributable to shareholders increased to $287.2 million or $0.76 per share from $189.3 million or $0.49 per share a year earlier but fell short of expectations.

At $3.4 billion, homebuilding revenue was up 6% compared to the year-ago quarter. Home closures advanced 7% to 11,500 units, while net sales orders rose by 3% to 11,042 units.

DR Horton purchased the homebuilding operations of Westport Homes, Classic Builders, and Terramor Homes for about $321 million in the second half of last year. During the December quarter, the management repurchased 4.1 million shares for $140.6 million. Recently, the company declared a quarterly cash dividend of $0.15 per share, to be paid on February 25, 2019, to stockholders of record on February 11, 2019.

DR Horton has purchased the homebuilding operations of Westport Homes, Classic Builders, and Terramor Homes for about $321 million

“Sales prices for both new and existing homes have increased across most of our markets over the past several years, which coupled with rising interest rates has impacted affordability and resulted in some moderation of demand for homes, particularly at higher price points,” said, Donald Horton, chairman of the board.

ADVERTISEMENT

Looking ahead, the company expects the homebuilding sector to benefit from the favorable supply-demand variation, booming economy and credit availability. It is anticipated that the positive factors, combined with DR Horton’s superior product offerings, will drive growth in the upcoming quarters.

DR Horton tanks after Q4 results miss market expectations

The domestic housing market has been going through a period of uncertainty, with rising mortgage rates and higher prices dampening demand across the market.

DR Horton shares closed the last trading session up 3%. The stock, which lost about 24% in the last twelve months, declined Friday after the earnings report.

ADVERTISEMENT

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

ADVERTISEMENT